Partilhar
Informação da revista
Conteúdo especial sobre o coronavírus SARS-CoV-2 (COVID-19) em Revista Portuguesa de Cardiologia
RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
Rodolfo P. Rothlin, Facundo Pelorosso, Mariano Duarte, Liliana Nicolosi, Ignacio Fernandez Criado, María Victoria Salgado, Héctor Vetulli
10.1016/j.repc.2023.08.005
Rev Port Cardiol. 2024;43:219-20
Acesso de texto completo
Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
Jorge Gonçalves, Catarina D. Santos, Paula Fresco, Fernando Fernandez-Llimos
10.1016/j.repc.2023.10.005
Rev Port Cardiol. 2024;43:221-2
Acesso de texto completo
RAAS inhibitors in COVID-19: They are not all the same!
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
10.1016/j.repc.2023.04.008
Rev Port Cardiol. 2023;42:815-6
Acesso de texto completo
Reply to: RAAS inhibitors in COVID-19: Not all are created equal!
Jorge Gonçalves, Catarina D. Santos, Paula Fresco, Fernando Fernandez-Llimos
10.1016/j.repc.2023.06.003
Rev Port Cardiol. 2023;42:817-8
Acesso de texto completo
High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in Portugal: The PICT2RE observational study
Helena Cardoso, Carlos Tavares Bello, Luís Andrade, Francisco Sobral do Rosário, Joana Louro, Cláudia Nogueira, Elisabete Rodrigues, Nuno Bernardino Vieira, Teresa Carqueja
10.1016/j.repc.2022.04.011
Rev Port Cardiol. 2023;42:319-30
Acesso de texto completo
Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVID-19 severity
Jorge Gonçalves, Catarina D. Santos, Paula Fresco, Fernando Fernandez-Llimos
10.1016/j.repc.2022.02.014
Rev Port Cardiol. 2023;42:373-83
Acesso de texto completo
Anti-SARS-CoV-2 vaccine-induced myocarditis – real but, in general, rare and mild: A consensus statement from the Studies Committee of the Portuguese Society of Cardiology
José Pedro Sousa, David Roque, Cláudio Guerreiro, Rogério Teixeira
10.1016/j.repc.2023.01.003
Rev Port Cardiol. 2023;42:161-7
Open access
Impact of the COVID-19 pandemic on percutaneous coronary interventions in Portugal
Carlos Galvão Braga, Pedro Araújo Gonçalves, Pedro Cardoso, António Fiarresga, Lino Santos, Ana Domingues, Marco Costa, Rui Ferreira, José Duarte, Filipe Seixo, Rui Campante Teles, Hélder Pereira, João Carlos Silva, Renato Fernandes, José Baptista, Pedro Braga, João Costa, Pedro Farto e Abreu, Pedro Costa Ferreira, Graça Caires, Dinis Martins, Paulino Sousa, João Brum da Silveira
10.1016/j.repc.2021.03.021
Rev Port Cardiol. 2023;42:1-6
Open access
The day after the COVID crisis
Hélder Pereira
10.1016/j.repc.2022.08.008
Rev Port Cardiol. 2023;42:7-8
Open access
Reply to the Letter to the Editor: Takotsubo syndrome in the setting of COVID-19: Pathogenetic and diagnostic implications
Kristian Rivera, Diego Fernández-Rodríguez, Marta Zielonka, Juan Casanova-Sandoval
10.1016/j.repc.2022.08.004
Rev Port Cardiol. 2022;41:895
Open access
Publicar em
Revista Portuguesa de Cardiologia
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.